Cambridge Investment Research Advisors
IBD icon

Cambridge Investment Research Advisors’s Inspire Corporate Bond ETF IBD Stock Holding History

Cambridge Investment Research Advisors’s Portfolio IBD Stock Details IBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Sell
47,251
-17,546
-27% -$418K ﹤0.01% 2199
2026
Q1 		$1.55M Buy
64,797
+1,805
+3% +$43.5K ﹤0.01% 1813
2025
Q4 		$1.52M Sell
62,992
-1,615
-2% -$39.1K ﹤0.01% 1767
2025
Q3 		$1.56M Sell
64,607
-4,658
-7% -$112K ﹤0.01% 1697
2025
Q2 		$1.66M Sell
69,265
-475
-0.7% -$11.3K 0.01% 1563
2025
Q1 		$1.66M Sell
69,740
-462
-0.7% -$10.9K 0.01% 1468
2024
Q4 		$1.65M Sell
70,202
-3,435
-5% -$81.5K 0.01% 1501
2024
Q3 		$1.77M Buy
73,637
+29,596
+67% +$706K 0.01% 1449
2024
Q2 		$1.03M Buy
44,041
+17,267
+64% +$402K ﹤0.01% 1756
2024
Q1 		$629K Sell
26,774
-1,096
-4% -$25.8K ﹤0.01% 2071
2023
Q4 		$657K Buy
27,870
+915
+3% +$20.9K ﹤0.01% 1969
2023
Q3 		$610K Buy
26,955
+4,668
+21% +$107K ﹤0.01% 1926
2023
Q2 		$515K Buy
22,287
+4,420
+25% +$103K ﹤0.01% 2115
2023
Q1 		$418K Buy
17,867
+7,461
+72% +$173K ﹤0.01% 2218
2022
Q4 		$240K Sell
10,406
-6,148
-37% -$140K ﹤0.01% 2609
2022
Q3 		$375K Buy
+16,554
New +$388K ﹤0.01% 2173
2021
Q1 		– Sell
-11,459
Closed -$305K – 2926
2020
Q4 		$305K Buy
11,459
+2,020
+21% +$53.4K ﹤0.01% 2126
2020
Q3 		$248K Sell
9,439
-508
-5% -$13.4K ﹤0.01% 2081
2020
Q2 		$262K Hold
9,947
– – ﹤0.01% 1987
2020
Q1 		$242K Buy
9,947
+1,226
+14% +$31.2K ﹤0.01% 1816
2019
Q4 		$224K Sell
8,721
-1,833
-17% -$47.2K ﹤0.01% 2123
2019
Q3 		$271K Buy
+10,554
New +$271K ﹤0.01% 1902

Other funds holding IBD

IA
Inspire Advisors Meridian, Idaho $1.44B AUM 26.8% 1-Year Est. Return
FA
Faithward Advisors Lancaster, Pennsylvania $819M AUM 41.44% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
BFS
Bare Financial Services Gap, Pennsylvania $436M AUM 20.22% 1-Year Est. Return
II
Inspire Investing Meridian, Idaho $2.43B AUM 49.04% 1-Year Est. Return
OFS
OneAscent Financial Services Birmingham, Alabama $2.09B AUM 24.1% 1-Year Est. Return
PFG
PAX Financial Group San Antonio, Texas $673M AUM 21.2% 1-Year Est. Return
PAW
Plan A Wealth Lincoln, Nebraska $235M AUM 22.68% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Cambridge Investment Research Advisors's IBD Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Inspire Corporate Bond ETF (IBD) stake by 27% in Q2 2026, selling an estimated $418K and leaving 47,251 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2199.

Cambridge Investment Research Advisors first reported a position in IBD in Q3 2019 and has held it in 22 quarters since. The position peaked at $1.77M in Q3 2024. 110 funds tracked by Wall St. Rank hold IBD as of Q2 2026.

  • Cambridge Investment Research Advisors held 47,251 shares of Inspire Corporate Bond ETF worth $1.12M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 17,546 Inspire Corporate Bond ETF shares in Q2 2026, an estimated $418K.
  • Inspire Corporate Bond ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2199 holding.
  • Cambridge Investment Research Advisors first reported a position in Inspire Corporate Bond ETF in Q3 2019 and has held it in 22 quarters since.
  • Cambridge Investment Research Advisors's Inspire Corporate Bond ETF position peaked at $1.77M in Q3 2024.
  • 110 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.